News & Events

Deutsch:

Das Labor für Radiochemie (LRC) und das Zentrum für Radiopharmazeutische Wissenschaften (CRS) sind zentrale Partner bei der Entwicklung der neuen TATTOOS-Einrichtung, einem Kernstück des IMPACT-Projekts, für das kürzlich vom Schweizer Parlament die Finanzierung bewilligt wurde. TATTOOS wird die Produktion essenzieller Radionuklide für hochmoderne Radiopharmazeutika ermöglichen und damit die Krebsdiagnostik und -behandlung revolutionieren. Aufbauend auf der Expertise des PSI und seinem Protonenbeschleuniger markiert diese Initiative einen bedeutenden Fortschritt in der personalisierten Krebstherapie und der Nuklearmedizin. Weitere Informationen finden Sie hier:

DE   https://www.psi.ch/de/news/medienmitteilungen/impact-upgrade-an-psi-forschungsanlage-beschlossen

FR   https://www.psi.ch/fr/news/communiques-de-presse/decision-concernant-impact-la-mise-a-niveau-de-l-installation-de

 

English:

The Laboratory of Radiochemistry (LRC) and the Centre for Radiopharmaceutical Sciences (CRS) are key partners in the development of the emerging TATTOOS facility, a cornerstone of the IMPACT project recently approved for funding by the Swiss Parliament. TATTOOS will enable the production of essential radionuclides for cutting-edge radiopharmaceuticals, revolutionising cancer diagnostics and treatment. Building on PSI’s expertise and its proton accelerator, this initiative represents a significant advancement in personalised cancer therapy and nuclear medicine. For more information, click here:

EN   https://www.psi.ch/en/news/media-releases/impact-upgrade-at-psi-research-facility-approved

FR   https://www.psi.ch/fr/news/communiques-de-presse/decision-concernant-impact-la-mise-a-niveau-de-l-installation-de

 


The EMIM addresses the latest developments in morphological, functional and molecular imaging at all scales, including mass spectroscopy, microscopy, and noninvasive imaging in preclinical and exploratory clinical studies. This also includes new strategies for image-guided therapies and theranostics.

With 1000+ international participants, the EMIM has significantly grown while preserving its collaborative, inclusive, and lively atmosphere. It is packed with excellent science and serves as comprehensive and inspiring platform for multidisciplinary exchange and collaboration in this broad and wonderful field of imaging science.

Date: 12-15 March 2024
Venue: Alfândega Congress Centre
Porto, Portugal